Workday Shares Rise 5 After Raising Margin Forecast on AI Momentum Chemical Tank Rupture in Washington State One Dead Several Injured Raising Industrial Safety Alarms Fed Dissenters Explain Votes Against Statement Signaling Next Rate Move Could Be a Cut SP 500 MeltUp Scenario Could the Index Reach 8000 or Higher United Rentals Faces Mixed Analyst Sentiment Amid Industry Dynamics Salesforce CRM Q1 Earnings Beat Raises Investor Sentiment PureTech Health Q4 2024 Earnings EPS Misses Estimates as ClinicalStage Biotech Reports Results BXP Q1 2026 Earnings Strong EPS Surprise Driven by Operational Efficiency Medline Inc MDLN Q1 2026 Earnings EPS Surpasses Estimates by 949 Amidst Limited Revenue Disclosure STC Q1 2026 Earnings Strong EPS Surprise Drives Modest Stock Uptick XOMAP Q1 2026 Earnings EPS Misses Estimates Amid Ongoing Royalty Fluctuations Upstream Bio Inc UPB Q1 2026 Earnings Narrower Than Expected Loss Reflects Operational Discipline Chime Financial CHYM Edges Lower as Key Support Level Comes into Focus Adams Natural Resources Fund PEO Holds Steady Near Support as Energy Sector Stabilizes Oyster Enterprises II Acquisition Corp OYSE Holds Steady at 1028 in Quiet Trading Session Kandal M Venture FMFC Rallies 3 From Support Potential Breakout Above 041 in Sight BayFirst Financial Corp BAFN Declines 187 Approaches Support as Selling Pressure Intensifies Surging Gas Prices Hit LowerIncome Households Harder New York Fed Study Suggests United Rentals URI Q1 2026 Earnings EPS Surges Past Estimates by 72 as Stock Inches Higher Columbus McKinnon CMCO Gains 17 as Buyers Step in Near Support ARM Q1 2026 Earnings EPS Beat Fails to Lift Shares as Market Weighs Headwinds Champions Oncology CSBR Q1 2026 Earnings EPS Misses by Wide Margin as Company Posts Loss ODFL Q1 2026 Earnings Solid Earnings Beat Despite Uncertain Freight Environment SLS Q1 2026 Earnings WiderThanExpected Loss as Clinical Milestones Remain the Focus Permian Resources PR Q1 2026 Earnings Significant EPS Miss Amid Operational Headwinds TS Q1 2026 Earnings EPS Surpasses Estimates But Stock Slips Amid Uncertain Revenue Outlook Niagen Bioscience Inc NAGE Q1 2026 Earnings EPS Beats Estimates by 086 but Stock Declines 343